M J Manco-Johnson

Summary

Affiliation: University of Colorado Denver
Country: USA

Publications

  1. doi request reprint Consequences of switching from prophylactic treatment to on-demand treatment in late teens and early adults with severe haemophilia A: the TEEN/TWEN study
    M J Manco-Johnson
    Department of Pediatrics, University of Colorado and Children s Hospital Colorado, Aurora, CO 80045, USA
    Haemophilia 19:727-35. 2013
  2. doi request reprint Randomized, controlled, parallel-group trial of routine prophylaxis vs. on-demand treatment with sucrose-formulated recombinant factor VIII in adults with severe hemophilia A (SPINART)
    M J Manco-Johnson
    Department of Pediatrics, Hemophilia and Thrombosis Center, University of Colorado, Aurora, CO 80045, USA
    J Thromb Haemost 11:1119-27. 2013
  3. doi request reprint Treatment, survival, and thromboembolic outcomes of thrombotic storm in children
    Marilyn J Manco-Johnson
    Department of Pediatrics, The Children s Hospital, University of Colorado School of Medicine, Aurora, CO 80045, USA
    J Pediatr 161:682-8.e1. 2012
  4. doi request reprint Pharmacokinetics and safety of fibrinogen concentrate
    M J Manco-Johnson
    Mountain States Regional Hemophilia and Thrombosis Center, Department of Pediatrics, University of Colorado Denver, Aurora, CO 80010, USA
    J Thromb Haemost 7:2064-9. 2009
  5. doi request reprint Fibrinogen replacement therapy for congenital fibrinogen deficiency
    L Bornikova
    Hemophilia and Thrombosis Center, Department of Medicine, University of Colorado, Aurora, CO 80045, USA
    J Thromb Haemost 9:1687-704. 2011
  6. ncbi request reprint Physical therapy and imaging outcome measures in a haemophilia population treated with factor prophylaxis: current status and future directions
    M J Manco-Johnson
    Department of Pediatrics, Mountain States Regional Hemophilia and Thrombosis Centre, University of Colorado Health Sciences Centre, Denver, Colorado 800445 0507, USA
    Haemophilia 10:88-93. 2004
  7. ncbi request reprint Influence of factor VIII on overall coagulability and fibrinolytic potential of haemophilic plasma as measured by global assay: monitoring in haemophilia A
    N A Goldenberg
    Section of Hematology, Oncology, and Bone Marrow Transplantation, Department of Pediatrics, University of Colorado at Denver, Denver, USA
    Haemophilia 12:605-14. 2006
  8. pmc Peri-procedural bridging with low molecular weight heparin in patients receiving warfarin for venous thromboembolism: a pediatric experience
    A Moruf
    University of Colorado School of Pharmacy, Aurora, CO, USA
    Thromb Res 130:612-5. 2012
  9. ncbi request reprint Joint evaluation instruments for children and adults with haemophilia
    M J Manco-Johnson
    Department of Paediatrics, Mountain States Regional Hemophilia and Thrombosis Center, University of Colorado Health Sciences Center, Aurora, CO 80045 0507, USA
    Haemophilia 6:649-57. 2000
  10. ncbi request reprint A patient satisfaction survey for haemophilia treatment centres
    M R Hacker
    Mountain States Regional Hemophilia and Thrombosis Center, University of Colorado Health Sciences Center, Aurora, CO, USA
    Haemophilia 12:163-8. 2006

Detail Information

Publications10

  1. doi request reprint Consequences of switching from prophylactic treatment to on-demand treatment in late teens and early adults with severe haemophilia A: the TEEN/TWEN study
    M J Manco-Johnson
    Department of Pediatrics, University of Colorado and Children s Hospital Colorado, Aurora, CO 80045, USA
    Haemophilia 19:727-35. 2013
    ..Following a switch from prophylaxis to on-demand therapy, the number of bleeding events increased and HRQoL worsened in late teens and young adults with severe haemophilia A...
  2. doi request reprint Randomized, controlled, parallel-group trial of routine prophylaxis vs. on-demand treatment with sucrose-formulated recombinant factor VIII in adults with severe hemophilia A (SPINART)
    M J Manco-Johnson
    Department of Pediatrics, Hemophilia and Thrombosis Center, University of Colorado, Aurora, CO 80045, USA
    J Thromb Haemost 11:1119-27. 2013
    ..The benefits of routine prophylaxis vs. on-demand treatment with factor VIII products have not been evaluated in controlled clinical trials in older patients with hemophilia A...
  3. doi request reprint Treatment, survival, and thromboembolic outcomes of thrombotic storm in children
    Marilyn J Manco-Johnson
    Department of Pediatrics, The Children s Hospital, University of Colorado School of Medicine, Aurora, CO 80045, USA
    J Pediatr 161:682-8.e1. 2012
    ..To describe the course and management of thrombotic storm in 8 children...
  4. doi request reprint Pharmacokinetics and safety of fibrinogen concentrate
    M J Manco-Johnson
    Mountain States Regional Hemophilia and Thrombosis Center, Department of Pediatrics, University of Colorado Denver, Aurora, CO 80010, USA
    J Thromb Haemost 7:2064-9. 2009
    ..Although fibrinogen concentrate has been available for the treatment of congenital fibrinogen deficiency for years, knowledge of its pharmacokinetics comes from only two small studies...
  5. doi request reprint Fibrinogen replacement therapy for congenital fibrinogen deficiency
    L Bornikova
    Hemophilia and Thrombosis Center, Department of Medicine, University of Colorado, Aurora, CO 80045, USA
    J Thromb Haemost 9:1687-704. 2011
    ..Fibrinogen replacement therapy requires careful monitoring of fibrinogen levels. Afibrinogenemia is associated with thromboembolic complications with or without treatment...
  6. ncbi request reprint Physical therapy and imaging outcome measures in a haemophilia population treated with factor prophylaxis: current status and future directions
    M J Manco-Johnson
    Department of Pediatrics, Mountain States Regional Hemophilia and Thrombosis Centre, University of Colorado Health Sciences Centre, Denver, Colorado 800445 0507, USA
    Haemophilia 10:88-93. 2004
    ..88 and 0.87; test-retest reliability was 0.92 and 0.93. These new PT and MRI scales promise to improve outcome assessment in children on early preventive treatment regimens...
  7. ncbi request reprint Influence of factor VIII on overall coagulability and fibrinolytic potential of haemophilic plasma as measured by global assay: monitoring in haemophilia A
    N A Goldenberg
    Section of Hematology, Oncology, and Bone Marrow Transplantation, Department of Pediatrics, University of Colorado at Denver, Denver, USA
    Haemophilia 12:605-14. 2006
    ..These findings indicate that the CloFAL assay may be useful as an adjunctive test to FVIII activity measurements in the therapeutic monitoring of haemophilia A...
  8. pmc Peri-procedural bridging with low molecular weight heparin in patients receiving warfarin for venous thromboembolism: a pediatric experience
    A Moruf
    University of Colorado School of Pharmacy, Aurora, CO, USA
    Thromb Res 130:612-5. 2012
    ..We sought to determine the risks of recurrent TE (both VTE and arterial TE [ATE]) and major bleeding with peri-procedural LMWH bridging in children receiving warfarin for VTE...
  9. ncbi request reprint Joint evaluation instruments for children and adults with haemophilia
    M J Manco-Johnson
    Department of Paediatrics, Mountain States Regional Hemophilia and Thrombosis Center, University of Colorado Health Sciences Center, Aurora, CO 80045 0507, USA
    Haemophilia 6:649-57. 2000
    ..35) and this instrument had better overall statistical performance. This instrument should be studied further in prospective, longitudinal clinical trials of young children...
  10. ncbi request reprint A patient satisfaction survey for haemophilia treatment centres
    M R Hacker
    Mountain States Regional Hemophilia and Thrombosis Center, University of Colorado Health Sciences Center, Aurora, CO, USA
    Haemophilia 12:163-8. 2006
    ....